Camp4 Therapeutics (CAMP) Other Non Operating Income (2024 - 2026)
Camp4 Therapeutics (CAMP) posted Other Non Operating Income of -$6.2 million for Q1 2026, up 77.92% sequentially from -$28.0 million in Q4 2025.
Analysis
Camp4 Therapeutics (CAMP) Other Non Operating Income (2024 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Other Non Operating Income for 3 years, with the latest figure at -$6.2 million in Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.0 million (down 124141.38% YoY) and the FY2025 annual result came in at -$29.8 million, changed N/A from the prior year.
- Other Non Operating Income grew to -$6.2 million in Q1 2026 per CAMP's latest filing, from -$28.0 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $178000.0 in Q4 2024 and troughed at -$28.0 million in Q4 2025.
- A 3-year average of -$4.5 million and a median of -$103500.0 in 2024 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 91.72% in 2025, down 15847.19% in 2025.
- Over 3 years, Other Non Operating Income stood at $178000.0 in 2024, then plunged by 15847.19% to -$28.0 million in 2025, then surged by 77.92% to -$6.2 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$6.2 million, -$28.0 million, and -$1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.93 Mn |
| Mar 31, 2026 | -6.19 Mn |
| Dec 31, 2025 | -28.03 Mn |
| Sep 30, 2025 | -1.80 Mn |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | -62,000.00 |
| Jun 30, 2024 | -145,000.00 |
| Mar 31, 2024 | 28,000.00 |